Further examination of the DEPs revealed that several signaling molecules previously identified at the tumor boundary, including ITGB4, COL1A2, and VIM, were significantly upregulated in the cancer-adjacent tissue (p.adjust < 0.05). The gene discussed is COL1A2; the disease is cancer.